Retraction: Peripheral blood mono-nuclear cells implantation in patients with peripheral arterial disease: A pilot study for clinical and biochemical outcome of neoangiogenesis (BMC Surgery (2016) 16:24 DOI: 10.1186/1471-2482-12-S1-S1);Peripheral blood mono-nuclear cells implantation in patients with peripheral arterial disease: A pilot study for clinical and biochemical outcome of neoangiogenesis

BMC Surgery

Volumn 12, Issue SUPPL. 1, 2012, Pages

  Amato, Bruno ^a   Compagna, Rita ^a   Della Corte, Gianni Antonio ^a   Martino, Giovanni ^a   Bianco, Tommaso ^a   Coretti, Guido ^a   Rossi, Roberto ^a   Braucci, Antonio ^a   Aprea, Giovanni ^a   Zeppa, Pio ^b   Puzziello, Alessandro ^c   Terranova, Claudio ^d  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^d UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

AGED; ANGIOGENESIS; ARTICLE; BLOOD; CLINICAL TRIAL; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LIMB; MALE; MIDDLE AGED; MONONUCLEAR CELL; PAIN ASSESSMENT; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PILOT STUDY; QUALITY OF LIFE; RADIOGRAPHY; TRANSPLANTATION; TREATMENT OUTCOME; VASCULARIZATION;

AGED; BIOLOGICAL MARKERS; EXTREMITIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; PAIN MEASUREMENT; PERIPHERAL ARTERIAL DISEASE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PILOT PROJECTS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 84869471090     PISSN: None     EISSN: 14712482     Source Type: Journal    
DOI: 10.1186/s12893-016-0138-1     Document Type: Erratum

References (20)

1. Cell therapy, a new standard in management of chronic critical limb ischemia and foot ulcer. Procházka V, Gumulec J, Jalvka F, Salounová D, Jonszta T, Czern D, Kraja J, Urbanec R, Klement P, Martinek J, Klement GL, Cell Transplantation 2010 19 1413 24 10.3727/096368910X514170 20529449
2. Walking performance and health-related quality of life after surgical or endovascular invasive versus non-invasive treatment for intermittent claudication - a prospective randomised trial. Norstanstig J, Gelin J, Hensater M, Taft C, et al. Eur J Vasc Endovasc Surg 2011 42 2 220 7 10.1016/j.ejvs.2011. 02.019 21397530
3. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Concensus (TASC). Dormandy JA, Rutherford RB, J Vasc Surg 2000 31 1 S296 10666287
4. Mechanisms of angiogenesis and arteriogenesis. Carmeliet P, Nat Med 2000 6 389 395 10.1038/74651 10742145 (Pubitemid 30208155)
5. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, Ferrara N, Symes JF, Isner JM, J Clin Invest 1994 93 662 670 10.1172/JCI117018 7509344
6. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. Harada K, Grossman W, Friedman M, Edelman ER, Prasad PV, Keighley CS, Manning WJ, Sellke FW, Simons M, J Clin Invest 1994 94 623 630 10.1172/JCI117378 7518840 (Pubitemid 24250992)
7. Clinical applications of angiogenic growth factors and their inhibitors. Ferrara N, Alitalo K, Nat Med 1999 5 1359 1364 10.1038/70928 10581076
8. Gene transfer as a tool to induce therapeutic vascular growth. Yla-Herttuala S, Alitalo K, Nat Med 2003 9 694 701 10.1038/nm0603-694 12778168 (Pubitemid 36749218)
9. Isolation of putative progenitor endothelial cells for angiogenesis. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM, Science 1997 275 964 967 10.1126/science.275.5302.964 9020076 (Pubitemid 27087709)
10. Evidence for circulating bone marrow-derived endothelial cells. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida A, Fujita Y, Kothari S, Mohle R, Sauvage LR, Moore MA, Storb RF, Hammond WP, Blood 1998 92 362 367 9657732 (Pubitemid 28323695)
11. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM, Circ Res 1999 85 221 228 10.1161/01.RES.85.3.221 10436164 (Pubitemid 29377293)
12. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Rafii S, Lyden D, Nat Med 2003 9 702 712 10.1038/nm0603-702 12778169 (Pubitemid 36749219)
13. Autologous bone marrow implantation induced angiogenesis and improved deteriorated exercise capacity in a rat ischemic hindlimb model. Ikenaga S, Hamano K, Nishida M, Kobayashi T, Li TS, Kobayashi S, Matsuzaki M, Zempo N, Esato K, J Surg Res 2001 96 277 283 10.1006/jsre.2000.6080 11266284 (Pubitemid 34969444)
14. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Shintani S, Murohara T, Ikeda H, Ueno T, Sasaki K, Duan J, Imaizumi T, Circulation 2001 103 897 903 10.1161/01.CIR.103.6.897 11171801 (Pubitemid 32163891)
15. Improved angiogenic potency by implantation of ex vivo hypoxia prestimulated bone marrow cells in rats. Li TS, Hamano K, Suzuki K, Ito H, Zempo N, Matsuzaki M, Am J Physiol Heart Circ Physiol 2002 283 468 H473 12124190
16. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, Amano K, Kishimoto Y, Yoshimoto K, Akashi H, Shimada K, Iwasaka T, Imaizumi T, Lancet 2002 360 427 435 10.1016/S0140-6736(02)09670-8 12241713
17. Endothelial progenitor cells: characterization and role in vascular biology. Urbich C, Dimmeler S, Circ Res 2004 95 343 353 10.1161/01.RES. 0000137877.89448.78 15321944 (Pubitemid 39100452)
18. Bone-marrow-derived cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences. Kinnaird T, Stabile E, Burnett MS, Epstein SE, Circ Res 2004 95 354 363 10.1161/01.RES.0000137878. 26174.66 15321945 (Pubitemid 39100453)
19. Critical roles of muscle-secreted angiogenic factors in therapeutic neovascularization. Tateno K, Minamino T, Toko H, Akazawa H, Shimizu N, et al. Circ Res 2006 98 1194 1202 10.1161/01.RES.0000219901.13974.15 16574905 (Pubitemid 43948106)
20. Long-term outcome of therapeutic neovascularization using peripheral blood mononuclear cells for limb ischemia. Moriya Junji, Minamino Tohru, Tateno Kaoru, Shimizu Naomi, Kuwabara Yoichi, Sato Yasunori, Saito Yasushi, Komuro Issei, Circ Cardiovasc Interv 2009 2 245 254 10.1161/CIRCINTERVENTIONS.108. 799361 20031722